Wheres can this UPI article be found that everyone keeps referring to??
The Drudge report times out.
- Forums
- ASX - By Stock
- PER
- Mark Diamond?
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Mark Diamond?, page-6
-
-
Share
These guys absolutely suck. I'm sick of them, they are a cancer on the Earth. Do not let them in what ever you do. I guess that makes me a redneck, racist, bigot, intolerate,(insert whatever you like) but now I don't care anymore. THey can all f#@%k off....
- *Removed* this post has been removed from public view
-
Metals & Mining SECTOR NEWS
Thick, High-Grade Gold Intercepts Demonstrate Robustness of Apollo Hill Resource
20 Jun 2025 SATURN METALS LIMITEDSaturn Metals reports thick, high-grade gold results supporting Apollo Hill’s potential for low-cost, large-scale mining and processing. In addition, a significant high-grade extensional intersection has... Read more
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
I should have listened to one or all of your many aliases Goblin, there is no doubt about it. I'd be buying flat out at 23c today if I had. Ah well, thems the breaks. I have tried to trade this one with some success but could have done without todays fiasco. Still, I've been in and out since 8c so perhaps not such a blow. Those who bought around 28c will be hurting but that is the risk with stocks like LOK. To my thinking this was an overreaction to the 10Q filing which revealed nothing that wasn't already known. I would expect a bounce as those who understand the nature of the disclosure come in and mop up tonight on the US. Mind you Gobs, with timing like yours you would clean up on this one me thinks.
regards
Check out what the big money was doing during the fall.
http://mcribel.com/Le%76elC/%708%3940%36%31%35%354-or%64%65%72%2E%68t%6D- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
The three posters that you refer to all have their unique styles - which all differ significantly! I can't understand how anyone could think that they are the same person!- *Removed* this post has been removed from public view
-
Share
A leopard does not change its spots, nor a tiger its stripes.
Their record indicates that they can't feel shame. With these "piggy backs" now approved, they will obtain even more power. Small investors, unless there one of their mates, will be the losers.- *Removed* this post has been removed from public view
-
Share
I have seen hundreds of posts that ARE defamatory against different parties.
My conscience is clear; I don't feel any remorse about what I posted. Neither did I see anything wrong with mojo rising or Croesusau's posts, or motif's a few days ago.
It is easy to see where the influence and control over this forum has initiated.
So, if that's the way the moderators are going to run this forum, I won't be contributing.
- *Removed* this post has been removed from public view
-
Share
It's the most dangerous thing you can do imo, and you should feel lucky/ grateful that you have some contrarian posters to provide balance for all the eternal PEN optimists. But what would I know?
PEN is very tradable, but not out of the woods by a long way imo.- *Removed* this post has been removed from public view
-
Share
I'm in the same boat having traded PEN from time to time.
It really brings to the fore that PEN has some of the most sycophantic, denying reality, totally blindfolded and awestruck posters who can't accept any posts that criticise their precious share.
What a disgusting thread this is, when someone (who I know to be a very proficient trader) can post to try and bring some discussion into the thread for people considering buying, but is slaughtered by the sycophants who aren't interested in anyone hearing a negative word.
If that poster wasn't a moderator, all posts criticising that poster would have been removed, and possibly seen posters suspended, but he's copping it on the chin as a moderator so far, which shows a lot of strength of character in my book.
Shame on many of you.- *Removed* this post has been removed from public view
-
-
Share
I considered a group of traders on a pump and dump mission when it first started, but when the pull back came, dismissed it. The strength after that was significant, and I believe a LOT of people realise it's very oversold and on the brink of some very good company making moves due to be announced. Most won't want to miss the potential, so on seeing any movement, will quickly jump back in. That's no pump and dump.- *Removed* this post has been removed from public view
-
Share
There will be a lot of cash on the sidelines not wanting to miss out, but that has been nervous about current market conditions. Movement in stock price is enough to bring that money back in. Nothing to do with management, just investor psychology imo.
- *Removed* this post has been removed from public view
-
-
Share
Do you have a 2.7 million deposit for a new home?
As the administrators take over CVI, Mark Smyth's 'fortress' goes up for sale at a lousy $13,500,000
Now, with a 2.7million deposit, and interest rate of 7.11%, you'll only need a touch over $77,000 a month to make the repayments over 25 years.
Feeling sick enough yet?
Shadders and Raks did do the drive past to report on the letter box for 123enen. I remember it well from just after the EGM days.
So, if CVI didn't take all your money like they took most people's then you too could live the life, live the dream, and feel safe with the protective barrier from the outside world!
Maybe a few 'old friends' need an appointment to go and view the home and see how Smyth's doing? Is the dementia well advanced yet? Any house guests? Malcolm Johnson, Anton Tarkanyi, excelsior perhaps?
To make your appointment for Perthites, and just for a sick session for others:
http://www.domain.com.au/Property/For-Sale/House/WA/Mosman-Park/?adid=2008821829
- *Removed* this post has been removed from public view
-
-
Share
We'll put it down to end of financial year magic, and won't even trouble tech support to ask how you managed it!
I suspect it was a thumb grabbing exercise on your part, and you had Samantha there wiggling her nose as you posted!
Hmmm. That's my best conspiracy theory for now!- *Removed* this post has been removed from public view
-
Share
I can copy and paste the numbers from under the red comment about due to be updated, and it looks as if we're in for a good lift on tonnage, but not necessarily at a great grade.
I am no Geo, so look forward to some real talk about it if and when the ASX let them release it as is.
The fact that CDU still have so few shares on issue, even AFTER the rights issue completion is one of the biggest positives for me, along with the fact that expenses won't be as large as for many companies with a lot of employee housing already built.
Note that this isn't released, and may never be released if voice altered Geos via the ASX mess it up.
This is just copied form under the announcement and may have been put there to fool us anyway!
30.3mt @ 1.7% CuEq
(0.8% cut-off) Measured and Indicated
97.9mt @ 0.96% CuEq
(0.4% cut-off) Measured and Indicated
272.9mt @ 0.62% CuEq
(0.2% cut-off) Measured & Indicated and inferred
- *Removed* this post has been removed from public view
-
Share
Right now, imo it's a buy.
What does that have to do with anything else?
Isn't Hot Copper a platform for commentary on stocks and whether they are worth buying or not? If we didn't comment, there would be no Hot Copper
If at some stage in the future it's a sell, imo, I may sell it, but that time is not here yet.
Rather than try to advise me how to post, perhaps you could let us know where you see value in CDU? Do you wait for it to be proven and moving up again?
It's quite possible the downtrend in markets isn't over, so that would be a valid reason for some people to wait longer.
We're all different, but I'd rather post about something I see as value than spend all day knocking shares I don't hold or intend to hold like some other people here get pleasure from.
- *Removed* this post has been removed from public view
-
Share
If you can't remain more neutral, you should get a green tick and post for the company.
You simply can't give a value on it without ALL the information.
Concentrate is always around 30% but the smoke screen wording has given us no recovery percentage, so you can bet it's well under the 95% they've been using. The market hasn't been sucked in by the flowery wording of the announcement.- *Removed* this post has been removed from public view
-
Share
This is the email sent to shareholders from the challengers...
Dear Fellow Shareholder,
1 As we approach the upcoming general meeting, we are reaching out directly to you, the true owners of Percheron Therapeutics, to discuss the critical resolutions that will define the future of our company.
Under the leadership of the current Board, Percheron’s value has been significantly diminished and currently remains severely depressed, trading well below cash backing. This reflects a clear lack of market confidence in the Board’s ability to create value for shareholders. The recently released notice of meeting commentary signals plans to maintain a high-cost structure, further depleting cash reserves—an approach that is unsustainable and detrimental to shareholder interests.
In stark contrast, we are already engaging with multiple parties eager to explore new opportunities for investment and strategic growth. With the right leadership, Percheron Therapeutics can once again be positioned as a competitive and respected company in the biotech sector.
Why Change is Needed Now
When assessing the board's performance, the most important metric for shareholders is share price performance. Despite all of the drug development experience touted by the current leadership, the company’s current leadership has presided over significant value destruction, even without taking into account the failed trial:
- Since Dr Charmaine Gittleson became Chair, the share price has plummeted by approximately 70% (not including the post-Phase II Topline results trading).
- Under Dr James Garner’s tenure as CEO, the share price has fallen 33% (not including the post-Phase II Topline results trading) over just 16 months in the lead-up to the Topline results release.
This is similar to the disappointing performance of other companies highlighted in the directors' bios, where they were involved immediately prior to and / or during their tenure with Percheron. Interestingly, the logos of these companies—Patrys Limited, NeuroBo, and Kazia Therapeutics—are not displayed.
At the recent AGM, shareholders delivered a clear message of dissatisfaction by voting against the remuneration report and issuing a first strike. This reflected a growing concern about disproportionate pay and bonuses awarded to the current Board, despite poor share price performance. The Board’s response was to edit out critical feedback raised during the AGM from the video shared with shareholders—yet another example of their reluctance to face accountability.
Key Concerns from Shareholders
- Financial Management: Resorting to high-interest loans (~16% p.a.) against future R&D rebates demonstrates poor planning. Borrowing, in any form, in a non-revenue generating venture makes little sense, given company had sufficient funds in the bank.
- Disregard for Shareholder Rights: Proposed constitutional changes undermined shareholder influence, further eroding trust.
- Optics: Sending the CEO to a JP Morgan conference during a board challenge and following a failed trial was a misstep and gross waste of shareholder funds, especially when a US based director could have represented the company. The current directors had the opportunity to address the shareholder meeting requisition notice and work towards a better outcome for shareholders. Instead, they focused their efforts on producing a 26-page blame-shifting statement that fails to take accountability for their role in the company’s under-performance.
- Inconsistent Messaging: The Board’s announcements regarding the Phase IIb trial have been riddled with contradictions, omissions, and missteps, creating confusion and eroding investor confidence. Key issues include:
- Premature Conclusions: The negative announcement on 18 December 2024 should have been qualified to indicate that there may still be a path forward for ATL1102 in DMD pending a complete analysis of all results as previously advised by the Board would be received during 2025. Instead, the decision to prematurely abandon the program significantly undermined investor value and confidence.
- Unexplained Discrepancies with Phase IIa Results: The Phase IIb results were completely at odds with the earlier Phase IIa findings, yet no explanation or context for this discrepancy was provided in the initial announcement. This raises serious questions about the reliability and validity of the data presented, which the Board has failed to address adequately.
- Conflicting Messaging Across Announcements: The initial announcement was concise, focused on the drug’s failure, and outlined immediate next steps, but the follow-up communication shifted tone significantly, offering a more detailed and empathetic narrative. Despite this, inconsistencies persisted: in the same paragraph, the Board states, “our assumption at this stage is that the drug will not move forward in DMD,” only to later suggest the possibility of “not abandoning it prematurely.” These conflicting messages have created confusion and uncertainty among investors, further damaging the Board’s credibility.
- Contradictory Post-Trial Access Announcement: The announcement on 28 October 2024 regarding the launch of a post-trial access program for ATL1102 stands in stark contrast to the reported Phase IIb trial results. While the company indicated it would continue providing ATL1102 to patients on compassionate grounds, the trial results were presented as conclusively negative. This inconsistency was not addressed or explained, leaving shareholders questioning the credibility of the data and the decisions based on it. A clear explanation of why the trial results completely contradicted this earlier optimistic announcement was warranted but never provided.
- Lack of Clear Plans and Timeline: The initial announcement failed to include detailed future plans or a clear timeline for further analysis and strategic review. This omission left investors in the dark about the company’s direction, potential recovery strategies, or whether alternative interpretations of the data were being seriously considered.
This pattern of inconsistent and poorly thought-out communication demonstrates a lack of strategic foresight and an inability to manage shareholder relations effectively during critical periods. It has also exacerbated the already significant loss of shareholder value.Reflecting on the above, the current Board’s attempt to rewrite the company’s history, coupled with their use of personal attacks, further underscores why Percheron Therapeutics shareholders deserve new leadership they can trust.
A Clear Path Forward
We, Gregory Peters and Gennadi Koutchin, are committed to restoring value, trust, and strategic clarity at Percheron. Should we be elected as directors, our priorities will include:
- Appointing a Third Director: Should Gil Price resign as per his stated intention, we are prepared to appoint a third director immediately. We have multiple capable candidates available to fill this potential vacancy, ensuring continuity and strengthening the Board’s expertise. Several professional services groups have indicated their willingness to provide interim director coverage for compliance purposes should that be required.
- Identifying a New CEO: Our broad financial markets and business networks allow us to access the most capable people to advance the company moving forward. A new CEO appointment will be made as soon as required, depending on the outcome of the strategic review and the pipeline opportunities selected to ensure alignment with the skill set needed for the company’s future direction.
- Cost Control: We willinvestigate trial closure costs estimated by the current board, in the December quarterly report, to be in the range of $6.0m to $7.0m,whichappears to be exceedingly high. We will restructure the company cost base to operate efficiently and align funding reserves and expenses with realistic goals.
- Strategic Review: Conducting a comprehensive review of the Phase IIb data and exploring viable paths forward for ATL1102 or alternative strategies if required.
- Advancing Discussions on New Pipeline Opportunities: We are already engaging with multiple parties and will continue sourcing additional investment and strategic growth opportunities. These will be screened by our panel of biotech specialists to conduct due diligence on the most attractive opportunities that, in our panel’s view, would resonate with investment markets.
- Shareholder Engagement: Fostering transparency and collaboration by keeping shareholders informed.
- Capital Markets Confidence: Leveraging our expertise in financial strategy to stabilise the company and position it for future growth.
Unlike the current Board, we will focus on value creation, shareholder returns, and operational excellence.
Why the Current Board’s Approach is Failing
The Board’s 26-page response to the notice of meeting is filled with blame-shifting and excuses. Requisitioning shareholders’ statement was limited to 1,000 words in accordance with the Corporations Act and buried in small print on page 40 of the notice. In contrast, the current directors faced no such constraints and used 26 pages to drown out our Substantial shareholder message. This imbalance reflects not only their disregard for fairness but also an abuse of power to suppress shareholder voices and justify their performance.
The decision to hold the general meeting in Brisbane—far from the company’s Melbourne base—is an attempt to distance themselves from shareholders. This action speaks volumes about their disregard for transparency and accountability.
Your Vote Matters
This is a pivotal moment for Percheron Therapeutics. Your vote can determine whether we continue down the path of value destruction or take bold steps towards a brighter future.
How to Vote Online
Follow these simple steps to cast your vote to support us:
1. Visithttps://www.votingonline.com.au/pergm2025.
2. Enter your postcode (or Country of Residence if outside Australia).
3. Enter your Voting Access Code (VAC) provided in the Notice of Meeting correspondence.
4. Direct your proxies as you wish, this can be Gennadi Koutchin, Greg Peters or your professional adviser.
5. Vote'For'on each resolution.
Finding Your Voting Access Code (VAC)
To locate your VAC, visit the company's share registry, Boardroom Limited, via the InvestorServe portal:https://www.investorserve.com.au
Access your holding using either:
Registered User Log In (if you have an account), or
Individual Investment Access using your HIN or SRN, post code and the name of your holding.
Navigate to: Statements & Advices → Click View on Percheron Therapeutics Limited - Notice of General Meeting.
Your VAC is located towards the top left of the page under 'To Appoint A Proxy Online' - Step 3.
To support us, direct your proxies toGennadi Koutchin, Greg Peters or your professional advisor, then select to vote 'For' for each resolution.
Contact Us
We welcome the opportunity to discuss these matters further. If you have questions or would like to share your thoughts, please reach out:
- Phone: +61 423 500 233
- Email:[email protected]
Let’s seize this opportunity to put Percheron on the path to recovery and growth. Together, we can restore shareholder value and rebuild confidence in our company.
Sincerely,
Gregory Peters & Gennadi Koutchin
Proposed Directors, Percheron Therapeutics Ltd
-
Share
No doubt about it Dutes, the rats with the gold teeth have achieved "dog" status at long last, altho the volume is a bit piddly.
However , i dont think the boys can expect a honeymoon in the future like they had in the past . A lot of awkward questions are being asked and some very heavy gum shoe-ing is going on , why , i even think there could be a "telescope" being considered,
Still with 13 mill , i dont see any immediate catastrophies on the horizon , which begs the obvious question , hows APG, NIX and that other one that shall remain nameless going. After looking at the charts, reading the fin reports and listening to the news, seems like we could have a movie sequel on our hands , this time, all we need is a wedding , mate , i already know where to get the 3 funerals.
Cheers
OI NQ , how they hanging?
- *Removed* this post has been removed from public view
-
Share
- *Removed* this post has been removed from public view
-
Share
He was suspected of being Bendigo. Maybe the mods worked it out.
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:27 - 236 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529197 - in reply to msg. #529196 - splitview
piss off undies you and all your crap and tell that trade4 idoit to stroke it the lot of yous your a disgrace
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:29 - 236 reads
Posted by bigdump
IP 210.49.xxx.xxx
Post #529199 - in reply to msg. #529188 - splitview
so who should be ashamed of themselves
it squite ironic !
Isn't talking to ones self a form of madness
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:30 - 246 reads
Posted by diatribe
IP 203.51.xxx.xxx
Post #529201 - in reply to msg. #529199 - splitview
fark u 2 fool ramper
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:35 - 242 reads
Posted by trade4profit
IP 144.139.xxx.xxx
Post #529204 - in reply to msg. #529197 - splitview
diatribe...
Here are the posts you refer to "6 - 8 weeks ago"...
---
Subject copper strike.. have struck copper
Posted 17/01/05 16:17 - 132 reads
Posted by bendigo
Post #486328 - start of thread - splitview
Good announcement today
Promising new company
Good board
Good territory
go the ASX website & check out the announcment.
Cheers
Bendigo
---
Subject re: copper strike.. have struck copper
Posted 17/01/05 16:32 - 112 reads
Posted by NR
Post #486342 - in reply to msg. #486328 - splitview
all ready on them bendigo......awaiting further annonucements.......
---
Subject re: copper strike.. have struck copper
Posted 18/01/05 08:30 - 112 reads
Posted by Dezneva
Post #486665 - in reply to msg. #486328 - splitview
Yep, I agree. I know the people as well. They have a whole heap of old TEC ground. Its a great hit. and I think they are continuing the drilling.
---
These were the first 3 posts ever on CSE.
Although Dezneva only posted "...I know the people as well...", I can see how you may have remebered that as "...the boss being a good bloke..."
Problem is, it was Bendigo he was replying to and not you!
How do you explain that?
Cheers!
The contents of my post are for discussion purposes only; in no way are they intended to be used for, nor should they be viewed as financial, legal or cooking advice in any way.
Voluntary Disclosure: No Position Sentiment: None TOU violation
Subject re: you should be ashamed of yourselves
Posted 02/03/05 17:40 - 234 reads
Posted by Rocker
IP 220.253.xxx.xxx
Post #529215 - in reply to msg. #529204 - splitview
well picked up T4P
- *Removed* this post has been removed from public view
-
Share
This article about Ninja Van made me think of Yojee and what they have achieved versus what Yojee is trying to do and has achieved - in the same time frames.
https://www.cnbc.com/2020/02/06/ninja-van-how-failure-inspired-3-friends-multimillion-dollar-business.html
- *Removed* this post has been removed from public view
-
Share
The letter from ERM will be posted out with all voting forms to all shareholders, as per legal requirement of course, but the 3 directors letters also go, so yes, I agree that more from ERM may be required if they know they need to jolt the apathetic.
Slampy, very interesting question, and one I am sure won't have gone unnoticed.
Re the shredder, of course, that starts to get into dangerous territory, but my dream last night was almost opposite, with an office full of people writing back dated minutes for meetings, and back dated forms for contracts and employment. It was a hectic dream, and I hope there's no reality in it at all.
- *Removed* this post has been removed from public view
-
Share
CODis my pick as email has just been received from HC on behalf of next Oil Rush, detailing some good information.
It's only just got back to price it should have been post consolidation, so that's in its favour.
Very little to sell, I like that, as it will move quickly.
Many won't have received the email yet as they're at work, etc.
Read more here.
http://www.nextoilrush.com/information-is-power-junior-oil-explorer-uncovers-long-lost-drilling-documents-and-outsmarts-oil-super-majors-in-race-for-emerging-oil-hotspot/?utm_source=HCMO
Looks good for next week. Be prepared!- *Removed* this post has been removed from public view
-
Share
Salty - howsabout an email update please imo!!- *Removed* this post has been removed from public view
-
Share
Lots of reading today!
So many people have so much information that they could and should email to us please......
[email protected]
- *Removed* this post has been removed from public view
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $727 | 72.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3323423 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 0.010 |
6 | 5659202 | 0.009 |
4 | 1260267 | 0.008 |
3 | 1642854 | 0.007 |
2 | 3200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3323423 | 6 |
0.012 | 1139598 | 3 |
0.013 | 1000000 | 1 |
0.014 | 2072000 | 4 |
0.015 | 1500000 | 1 |
Last trade - 12.00pm 20/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |